Pesquisar
Sanofi SA
SNYAdicionar à lista de desejos
43.160USD
+1.530+3.68%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
103.60BValor de mercado
12.00P/L TTM
Mais detalhes de Sanofi SA Empresa
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Informações de Sanofi SA
Código da empresaSNY
Nome da EmpresaSanofi SA
Data de listagemJul 01, 2002
CEOHudson (Paul)
Número de funcionários84587
Tipo de títulosDepository Receipt
Fim do ano fiscalJul 01
Endereço46 Avenue de la Grande Armee
CidadePARIS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísFrance
Código postal75017
Telefone33153774000
Sitehttps://www.sanofi.com/
Código da empresaSNY
Data de listagemJul 01, 2002
CEOHudson (Paul)
Executivos da empresa Sanofi SA
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
Mr. Thomas Triomphe
Mr. Thomas Triomphe
Executive Vice President - Vaccines, Member of the Executive Committee
Executive Vice President - Vaccines, Member of the Executive Committee
--
--
Ms. Barbara Lavernos
Ms. Barbara Lavernos
Director
Director
--
--
Mr. Wolfgang Laux
Mr. Wolfgang Laux
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Tran Yann
Mr. Tran Yann
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Roy Papatheodorou
Mr. Roy Papatheodorou
Executive Vice President, General Counsel, Member of the Executive Committee
Executive Vice President, General Counsel, Member of the Executive Committee
--
--
Mr. Brendan O' Callaghan
Mr. Brendan O' Callaghan
Executive Vice President - Global Manufacturing and Supply, Member of the Executive Committee
Executive Vice President - Global Manufacturing and Supply, Member of the Executive Committee
--
--
Ms. Carole Ferrand
Ms. Carole Ferrand
Independent Director
Independent Director
--
--
Mr. Emile Voest, M.D., Ph.D.
Mr. Emile Voest, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Antoine Yver, M.D.
Dr. Antoine Yver, M.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Julie Van Ongevalle
Ms. Julie Van Ongevalle
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
Executive Vice President - Consumer Healthcare, Member of the Executive Committee
--
--
Mr. Thomas Triomphe
Mr. Thomas Triomphe
Executive Vice President - Vaccines, Member of the Executive Committee
Executive Vice President - Vaccines, Member of the Executive Committee
--
--
Ms. Barbara Lavernos
Ms. Barbara Lavernos
Director
Director
--
--
Mr. Wolfgang Laux
Mr. Wolfgang Laux
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Tran Yann
Mr. Tran Yann
Director, Employee Representative
Director, Employee Representative
--
--
Mr. Roy Papatheodorou
Mr. Roy Papatheodorou
Executive Vice President, General Counsel, Member of the Executive Committee
Executive Vice President, General Counsel, Member of the Executive Committee
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Sanofi SA?
Os cinco principais acionistas de Sanofi SA são: Ms. Julie Van Ongevalle
Quantas instituições possuem ações da Sanofi SA (SNY)?
Em 2026Q1, 1330 instituições possuíam ações da Sanofi SA, com valor de mercado aproximado de 225.52M, representando 9.34% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -36323619.00.